Russian Federation vs United States of America: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Russian Federation
95.0%
in 2025
United States of America
95.0%
in 2025
Russian Federation rank
29th
United States of America rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Russian Federation
- United States of America
How they compare
Russian Federation currently reports 95.0% against 95.0% in United States of America, a difference of 0.0%.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Russian Federation ahead.
Russian Federation ranks 29th and United States of America ranks 29th of 194 countries.
Russian Federation has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Russian Federation | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.5% | 86.2% | 8.3% | Russian Federation |
| 2010s | 97.1% | 92.3% | 4.8% | Russian Federation |
| 2020s | 95.3% | 95.0% | 0.3% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Russian Federation or United States of America?
- Russian Federation, at 95.0% against 95.0% in United States of America as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Russian Federation and United States of America?
- 0.0%, with Russian Federation ahead.
- How many years of comparable data are there for Russian Federation and United States of America?
- 26 years are reported by both, from 2000 to 2025.
- How do Russian Federation and United States of America rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Russian Federation ranks 29th and United States of America ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.